12/16/2023 0 Comments Novavax news![]() ![]() "So, if you look at an image of it, it looks like a virus, but it cannot induce any disease. "The plant will assemble the protein in a shape and form that is looking like the virus," says Nathalie Landry, Medicago's executive vice president for scientific and medical affairs. The plants do something very valuable - they make a lipid shell that surrounds a bunch of the viral proteins, with the proteins sticking out. The plants used are related to the tobacco plant, and have been modified to contain the genetic instructions to make the viral protein. That's the approach being used by the Canadian biotech firm Medicago. But there's another way to make the protein: Get plants in a greenhouse to do it. To make the virus protein, Novavax uses giant vats of cells grown in the lab. Gregory Glenn, president of research and development for Novavax, told an audience at a recent webinar hosted by the International Society for Vaccines that "we anticipate filing for authorization in the U.K., U.S. There are vaccines on the market for hepatitis B and pertussis based on this technology.Ī large test of the Novavax COVID-19 vaccine's effectiveness, conducted in tens of thousands of volunteers in the United States and Mexico, is about to wrap up. Protein subunit vaccines made this way have been around for a while. In contrast to the three vaccines already authorized in the U.S., it contains the spike protein itself - no need to make it, it's already made - along with an adjuvant that enhances the immune system's response, to make the vaccine even more protective. The first protein subunit COVID-19 vaccine to become available will likely come from the biotech company, Novavax. ![]() Shots - Health News A Vaccine Patch Could Someday Be An Ouchless Option ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |